Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Brian Meissner, PharmD, PhD
Advertisement
Articles by Brian Meissner, PharmD, PhD
Advertisement
Latest Updated Articles
- Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence
Published: July 17th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
2
FDA Approves Second Generic Mifepristone Pill for Abortion
3
Transforming Psychiatry: The Rise of Prescription Digital Therapeutics
4
Colon Cancer Recurrence Risk Nearly Gone After 6 Years, Study Reveals
5
